According to the American Cancer Society, approximately 80% of new cancer diagnoses occur in individuals aged 55 years and older. Given the current population trajectory, which projects that approximately 20% of the population will be over the age of 65 by 2030, it is estimated that the incidence of cancer will continue to increase in years to come, from approximately 17.0 million in 2018 to 26.0 million in 2040. This is likely to result in a rise in demand for oncology providers in future years.

The different types of oncology specialties include medical, surgical, radiation, proton therapy, pediatric, and hematology. VMG Health has valuation experience in each, with extensive involvement in the medical, radiation, proton therapy and surgical space.

What We Do

  • Fair Market Value Opinions – Business Enterprise Valuations
  • Financial Reporting Valuations
  • Flexible FP&A (including Financial & Business Modeling on a Go-Forward Basis)
  • Quality of Earnings
  • Feasibility & Market Studies
  • Black Box & Reimbursement Analysis (including Bundle Payment Impact Analysis)
  • Proton Therapy and other modalities ‘Per Use’ Agreements
  • Physician Compensation Valuations – Professional & Technical Fee Split, Management Agreements, Compensation Valuations, Provider Compensation Design, Compensation Plan Implementation, Contract Analytics

VMG Health has extensive experience in a specialized suite of services related to Proton Therapy including:

  • Proton Therapy Valuations
  • Proton Therapy Feasibility Studies
  • Equipment & Services per Use Valuations
  • Trade Name & Brand Valuations

Relevant Oncology Publications

Oncology & COVID-19: Impacts & Outlook
Radiation Oncology Alternative Payment Model – Valuation & Transaction Considerations
Oncology on the Rise: Private Equity Investment in Cancer Care